Navigation Links
China Kangtai Cactus Biotech, Inc. Obtains $500,000 Equity Financing
Date:3/31/2008

-- Majority of Initial Proceeds to be Used for Marketing in 2008 --

HARBIN, China, March 31 /Xinhua-PRNewswire-FirstCall/ -- China Kangtai Cactus Biotech Inc. (the "Company") (OTC Bulletin Board: CKGT), a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based consumer products in China, today announced that the Company has entered into an equity purchase agreement with T Squared Investments LLC (the "Investor"), whereby T Squared Investments will invest $500,000 in the Company.

The Company intends to use the proceeds of the $500,000 investment to finance an aggressive marketing program in the domestic Chinese market with a goal to further penetrate and expose the large market demand of the cactus brand of China Kangtai. The Company also plans on acquiring additional equipment to enhance current and future production capacity. The remaining net proceeds of the financing will be used for product development and to institute a robust investor communication program.

The Company has in-place with the Investor an investment right and financing to provide an additional $6,500,000 for marketing, research & development, and growth purposes.

"We are excited to close this transaction with our new, long-term partner T Squared, as it will greatly help to realize our production and marketing strategy in 2008 onward," said Jinjiang Wang, President of CKGT.

Mark Jensen, of T Squared Partners LLC commented, "China Kangtai represents an exciting opportunity for the T Squared Partners LLC to invest in the rapidly expanding domestic cactus production industry in China. The Company's highly experienced management team has a proven track record of growth and we are very excited to be part of such a robust organization. We are confident that with our financial support, China Kangtai can increase its cactus production sales much more rapidly."

About China Kangtai Cactus Biotech, Inc.

China Kangtai Cactus Biotech Inc. is market-leading cactus grower and producer of cactus-related products with over 387 acres of plants and an active R&D group that holds 15 product patents and is seeking another 15 in a variety of product categories. China Kangtai's high-quality products are sold throughout China in supermarkets, food stores, hotels and restaurants through a growing distribution network that has currently covered 14 provinces and 4 municipalities.

About T Squared Investments LLC

T Squared Partners and T Squared Investments LLC is a fundamentally- oriented private investment firm focusing on special situation and value growth oriented micro-cap public and private companies. The fund's philosophy is to work with companies to enhance their shareholder value through friendly investment structures in addition to providing industry leading strategic advice.

Cautionary Statement Regarding Forward-looking Information

This press release contains forward-looking information about China Kangtai Cactus Biotech that is intended to be covered by the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology, and include discussions of strategy, and statements about industry trends and China Kangtai Cactus Biotech future performance, operations and products.

For more information, please contact:

Chengzhi Wang

General Manager

China Kangtai Cactus Biotech, Inc.

Tel: +86-132-065-88885

Email: az3039@163.com

Web: http://www.biocactus.com


'/>"/>
SOURCE China Kangtai Cactus Bio-Tech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Aida Pharmaceuticals, Inc. Acquires High-Level Research Institute in the Peoples Republic of China
2. Aida Acquires High-Level Research Institute in China
3. China Pharma Holdings, Inc. Announces Earnings Call for Fiscal 2007 Financial Results
4. China Biopharma Reaches Agreement with a Regional Pharma to Launch New Pharmaceutical Products
5. China Biologic Products Announces One of Its R&D Projects Has Been Listed In National Torch Plan
6. Lucids VivaScope(R) Reflective Confocal Microscope Approved for Sale in China
7. China Aoxing Pharmaceutical Company Signed Definitive Acquisition Agreement to Acquire Shijiazhuang Lerentang Pharmaceutical Company, Ltd.
8. Pharmaxis First Steps into China
9. Hovione Buys Drug Manufacturing Facility in China
10. China Nepstar Chain Drugstore to Acquire 18 Stores from Dongguan Hui Ren Tang Pharmaceutical Co.
11. China Yingxia International Announces Q4 and FY 2007 Estimates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
Breaking Biology Technology:
(Date:6/15/2016)... , June 15, 2016 ... report titled "Gesture Recognition Market by Application Market - Global Industry ... - 2024". According to the report, the  global gesture ... in 2015 and is estimated to grow at ... billion by 2024.  Increasing application of ...
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... project, for the , Supply and Delivery of ... Infrastructure , to Decatur , ... Management Solutions. Numerous renowned international vendors participated in the tendering ... selected for the most compliant and innovative solution. The contract ...
(Date:5/20/2016)... , May 20, 2016  VoiceIt is ... partnership with VoicePass. By working together, ... experience.  Because VoiceIt and VoicePass take slightly different ... engines increases both security and usability. ... excitement about this new partnership. "This ...
Breaking Biology News(10 mins):